Nrx-101
Suicidal Ideas
NeuroRx, Inc.Phase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Suicidal Ideas cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Federal University of São Paulo | Phase 3 | BB |
MIDAZOLAM Federal University of São Paulo | Phase 3 | B |
Same molecule, other indications
Nrx-101 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →